(Hypertension. 1995;26:1046-1050.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Internal Medicine, Hypertension and Vascular Research Laboratories, University of Texas Medical Branch, Galveston.
Correspondence to Donna H. Wang, MD, The University of Texas Medical Branch, Department of Internal Medicine, Hypertension and Vascular Research Laboratories, 8.104 Medical Research Bldg, Galveston, TX 77555-1065. E-mail dwang%intmedS1@mhost.utmb.edu.
| Abstract |
|---|
|
|
|---|
Key Words: gene transfer dependovirus organ culture aorta renal artery
| Introduction |
|---|
|
|
|---|
It has been shown that exogenous genes can be successfully transferred to rat aortic smooth muscle cells6 as well as intact or injured carotid arteries by adenovirus.5 11 12 Although transfection efficiencies are high, no studies have compared the efficiency of transfection between aorta and the smaller arteries. Considering the critical role of the kidney in the pathogenesis of clinical and experimental hypertension,14 15 16 17 this tissue is a reasonable target for gene transfection both at a basic science level and as a target for gene therapy. To provide information about the utility of gene transfer in the renal artery, we used adenovirus containing either firefly luciferase gene (Ad5-luc3) or Escherichia coli ß-galactosidase (ß-gal) gene (AdHCMVsp1LacZ) to determine whether the efficiencies of adenovirus-mediated gene delivery into organ cultures of thoracic aorta and renal artery are different.
| Methods |
|---|
|
|
|---|
Tissue Isolation and Organ Culture
Male Sprague-Dawley rats (Harlan Sprague Dawley Inc,
Indianapolis, Ind) weighing between 275 and 300 g were used. The rats
were anesthetized with a single
intraperitoneal injection of 80 mg/kg
ketamine and 1 mg/kg xylazine and then were decapitated.
Thoracic aorta (from aortic arch to diaphragm) and both renal arteries
(from aorta to kidney) were carefully removed as previously
reported.21 22 Both aorta and renal artery were cut into
fragments (3 mm) and placed in 60-mm dishes containing 5 mL
SFM21 22 consisting of Dulbecco's modified Eagle's
medium and F-12 nutrient mixture (1:1), glutamine (200 µg/mL),
penicillin (100 U/mL), streptomycin (100 µg/mL), insulin (5 µg/mL),
and transferrin (5 µg/mL). The vessels were then placed in a
humidified incubator with a 95% air/5% CO2 atmosphere at
37°C for 16 hours and used in either gene transfer or
[3H]thymidine uptake experiments. The aorta and renal
artery from each rat were placed in one dish; n always
represents the number of rats.
In Vitro Gene Transfer
After 16 hours of incubation, vessels in each batch were washed
twice in PBS and incubated in 0.3 to 0.5 mL PBS containing
2x109 pfu/mL adenovirus for 1 hour.12 20 This
adenovirus concentration was selected because our dose-response
experiments showed that it causes maximal transduction (Fig 1A). After two washes in PBS, vessels were refed with 5
mL SFM plus 10% FBS and incubated for 2 days. The vessels were then
homogenized in 50 to 100 µL buffer (100 mmol/L potassium
phosphate, pH 7.8, 1 mmol/L dithiothreitol, 100 µg/mL
phenylmethylsulfonyl fluoride, 0.1% Triton
X-100).18 After centrifugation for 10
minutes at 16 000g at 4°C, the supernatant was assayed
for luciferase or ß-gal activity.
|
Measurement of Luciferase and ß-Gal Activities
For determination of luciferase
activity,18 23 10 µL undiluted or serially diluted
supernatant was mixed with 100 µL luciferase assay buffer [20 mmol/L
Tricine, 1 mmol/L
(MgCO3)4Mg(OH)2·5H2O,
2.67 mmol/L MgSO4, 0.1 mmol/L EDTA, 33.3 mmol/L
dithiothreitol, 270 µmol/L coenzyme A, 470 µmol/L luciferin, 530
µmol/L ATP]. The light emission over the first 15 seconds of
reaction measured by an Autolumat LB 953 luminometer (LKB) was
recorded as RLU. Activity of ß-gal was measured in a 300-µL
reaction volume consisting of 10 to 40 µL supernatant, 100 mmol/L
sodium phosphate, pH 7.3, 1 mmol/L MgCl2, 50 mmol/L
ß-mercaptoethanol, and 0.67 mg/mL
o-nitro-prenol-ß-D-galactoside. After 30
minutes to 2 hours of incubation at 37°C, the reaction was stopped by
addition of 500 µL of 1 mol/L Na2CO3. The
optical density of each sample was measured at wavelength of 420 nm
with a spectrophotometer (Pharmacia Biotech Inc). Luciferase and
ß-gal activities were normalized by protein concentrations that
were determined with the use of a modified Bradford dye-binding
procedure (Bio-Rad).24
Histological Evaluation of ß-Gal
Staining
For evaluation of gene transfer at the
histological level6 11 12 transfected
vessels were fixed for 5 minutes in 2% formaldehyde and 0.2%
glutaraldehyde in PBS, pH 7.4. The vessels were then
washed in PBS several times and placed into X-Gal solution [5 mmol/L
K4Fe(CN)6, 5 mmol/L
K3Fe(CN)6, 1 mmol/L
MgCl2, 1 mg/mL X-Gal in PBS]. After 1 day of
staining at room temperature samples were postfixed in the same
fixative, cut into 5-µm-thick sections, and counterstained with
nuclear fast red. With the use of a computerized
image-analysis system25 the nuclei stained
with nuclear fast red and ß-galstained cells were counted
from two different circumscribed areas per section, eight sections per
rat, and a mean value was calculated for each. The percentage of
transduced endothelial cells was calculated as the
number of ß-galstained endothelial cells
divided by the total endothelial cells times 100%.
Because of the nonuniform distribution of the cell population in the
adventitia, the number of transduced adventitial cells was normalized
with the length of vessels in the circumscribed area.
[3H]Thymidine Uptake
DNA synthesis was measured by determination of
[3H]thymidine incorporation. Five milliliters SFM
containing 2 µCi/mL [3H]thymidine (Amersham) was placed
in the culture dishes described above. Two hours later the vessels were
washed with PBS three times and homogenized in 0.2 mol/L
PCA.26 After centrifugation at
1000g for 10 minutes the pellet was washed with 0.2 mol/L
PCA three times. The pellet was then resuspended and heated in 0.5
mol/L PCA for 20 minutes at 90°C to solubilize the DNA. After cooling
and recentrifugation at 1000g for 10
minutes the supernatant was used for DNA determinations.
[3H]Thymidine incorporation into DNA was assessed with a
liquid scintillation system (LS1801, Beckman Instruments Inc). Total
DNA content was determined by a fluorochrome compound (Hoechst 33258,
Sigma) with the use of a fluorescence spectrophotometer
(F-4500, Hitachi Co).27 [3H]Thymidine uptake
was normalized to micrograms of DNA content.
Statistical Analysis
All values are expressed as mean±SEM. Differences between
groups were determined by Student's t test and ANOVA
followed by the Tukey-Kramer multiple comparison test. Significance was
accepted at the level of P<.05.
| Results |
|---|
|
|
|---|
Fig 1B shows the duration of luciferase activity in the aorta after the transfection of 2x109 pfu/mL Ad5-luc3. The aortas from three rats were pooled and used for generation of one curve. Luciferase activity was detectable 24 hours after transfection, reaching maximal levels at about 2 days. Although luciferase activity was still easily detectable 7 days after transfection, expression levels were one order of magnitude lower than the peak activity. Luciferase activity returned to basal levels by 9 days after the transfection.
Fig 2A shows the levels of luciferase activity in extracts prepared from thoracic aorta and renal artery exposed to identical concentrations (2x109 pfu/mL) of Ad5-luc3 and AdHCMVsp1LacZ. Luciferase activity was undetectable in extracts from both thoracic aorta (n=4) and renal artery (n=4) exposed to AdHCMVsp1LacZ. Luciferase activity in renal artery exposed to Ad5-luc3 (15.9±2.1x106 RLU/mg protein, n=4) was significantly higher than that in thoracic aorta (8.3±2.0x106 RLU/mg protein, n=4, P<.05).
|
Fig 2B shows the levels of ß-gal activity in extracts prepared from thoracic aorta and renal artery exposed to the same concentrations (2x109 pfu/mL) of Ad5-luc3 and AdHCMVsp1LacZ. Activity of ß-gal was nearly undetectable in extracts from both thoracic aorta (n=4) and renal artery (n=4) exposed to Ad5-luc3. Again, ß-gal activity in renal artery exposed to AdHCMVsp1LacZ (17.7±2.8x10-3 U/mg protein, n=4) was significantly higher than that in thoracic aorta (7.5±2.1x10-3 U/mg protein, n=4, P<.05).
To determine the type and proportion of cells in the thoracic aorta and renal artery that expressed ß-gal, we stained tissue sections with X-Gal. As shown in Fig 3 dark blue ß-gal staining was noted in both endothelial and adventitial cells but not in the muscular media of thoracic aorta and renal artery exposed to AdHCMVsp1LacZ (Fig 3A and 3B). No ß-gal staining was detected in thoracic aorta and renal artery transfected with Ad5-luc3 (Fig 3C and 3D). Statistical analysis of the results of the ß-gal staining indicated that the percentage of ß-galstained endothelial cells in renal artery (36±4%, n=4) was significantly higher than that in thoracic aorta (22±1%, n=4, P<.05). The number of ß-galstained adventitial cells per unit length of renal artery (10.6±0.1/mm, n=4) was also modestly but significantly higher than that of thoracic aorta (7.7±0.7/mm, n=4, P<.05).
|
To assess whether the efficiency of the transfection is a function of the replication status of the cells, we cultured thoracic aorta with either SFM or SFM plus 10% FBS for 16 hours before transfection with Ad5-luc3. Luciferase activity in aorta cultured with SFM plus 10% FBS (6.5±0.1x106 RLU/mg protein, n=4) was significantly higher than that in aorta cultured with SFM (4.1±0.2x106 RLU/mg protein, n=4, P<.05), indicating that higher efficiency of the transfection is correlated with active growth status of the vessel. We therefore examined [3H]thymidine incorporation in both thoracic aorta and renal artery cultured with SFM. We found that [3H]thymidine uptake of renal artery (2798±235 cpm/µg DNA, n=4) was significantly higher than that of thoracic aorta (1769±220 cpm/µg DNA, n=4, P<.05).
| Discussion |
|---|
|
|
|---|
It has been demonstrated that adenovirus has several advantages over other gene-transfer methods.28 29 Among these advantages is exceptionally high efficiency, which is one of the most important features of this virus for therapeutic and research purposes.6 11 In the present experiments we found that exposure of cultured aorta to increasing concentrations of Ad5-luc3 (104 to 1010 pfu/mL) resulted in a dose-dependent increase in luciferase expression, with a peak expression of approximately 2x106 to 4x106 RLU luciferase per milligram protein. This result is consistent with the data obtained from in vivo experiments in which 1010 pfu/mL adenovirus produced maximally transduced cells in balloon-injured rat carotid arteries.11 The percentage of transduced endothelial cells in our cultured aorta and renal artery was approximately 20% to 40%, which is close to the 30% transfection rate in vivo.11 The failure to transfect the smooth muscle media may result from the barrier function of the internal elastic lamina because it has been demonstrated that when carotid arteries are denuded of endothelium, injection of adenovirus results in effective transfection of the smooth muscle cell.6 11 This high transfection efficiency in endothelial and adventitial cells suggests that it may be possible to use adenovirus-mediated gene transfer to study the effects of gene products of autocrine and/or paracrine factors that are linked with the pathogenesis or the prevention of vascular- related diseases.
Another important feature of adenovirus is that adenovirus genome does not integrate into host cell DNA, therefore obviating the hazard of insertional mutagenesis when applied in humans.29 However, this feature also makes permanent transfection impossible. It has been reported that expression of recombinant protein lasts for about 2 weeks after injection of adenovirus into the carotid artery.11 12 We found that luciferase expression in cultured aorta was detectable 7 days after transfection but was no longer evident at 9 days. The loss of responsiveness may be due to the lack of permanent integration of adenovirus DNA or the difficulty of maintaining live aorta in the culture. Nonetheless, the peak expression of luciferase can be detected as early as 2 days (Fig 1B), allowing the study of a high level of gene expression at known times.
Interestingly, the efficiencies of the transfection, assessed either at the histological level by counting of ß-galstained cells in intact vessels or at the biochemical level by measurement of ß-gal or luciferase activity in tissue extracts, were higher in renal artery than thoracic aorta. These results indicate that there is considerable heterogeneity of the efficiency of adenovirus-mediated gene transfer according to either the anatomic location or size of the vessels studied. If this phenomenon holds true in vivo, it may have significant clinical implications. It has been demonstrated that early narrowing of the afferent arteriole contributes to the development of hypertension in spontaneously hypertensive rats.30 Narrowing of the renal artery also causes rapid development of renal hypertension.31 It is therefore conceivable that in cases in which the renal artery itself is the target for gene therapy, the ability to deliver gene products by adenovirus transfection may be highly site specific.
The mechanisms whereby adenovirus causes higher transfection efficiency in renal artery is not clear. The fact that the aorta cultured with serum had higher luciferase activity than that cultured without serum indicates that transfection efficiency may be associated with the proliferative state of the vessel. We found that DNA synthesis assessed by [3H]thymidine uptake in renal artery was significantly higher than that in thoracic aorta, indicating that the enhanced turnover rate of renal artery cells may contribute to increased transfection efficiency in renal artery. Furthermore, it is possible that different transfection efficiencies between the renal artery and thoracic aorta are caused by a heterogeneous distribution of adenovirus receptors between these two vessels.32 Further investigation into these areas is needed.
In conclusion, we demonstrate that adenovirus effectively transfers gene into organ cultured aortic and renal arterial endothelial and adventitial cells. The efficiency of the transfection is significantly higher in renal artery than thoracic aorta. Our data demonstrate the feasibility of using the renal artery as a target for the treatment of diseases such as hypertension and of providing a model for investigation of the interplay of vascular-derived factors and their roles in the pathogenesis of vascular-related diseases.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received June 18, 1995; first decision August 18, 1995; accepted August 18, 1995.
| References |
|---|
|
|
|---|
2.
Flugelman MY, Jaklitsch MT, Newman KD, Casscells W,
Bratthauer GL, Dichek DA. Low level in vivo gene transfer into
the arterial wall through a perforated balloon
catheter. Circulation. 1992;85:1110-1117.
3. Leclerc G, Gal D, Takeshita S, Nikol S, Isner JM. Percutaneous arterial gene transfer in a rabbit model: efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest. 1992;90:936-944.
4.
Miller DG, Adam MA, Miller AD. Gene transfer by
retrovirus vectors occurs only in cells that are actively replicating
at the time of infection. Mol Cell Biol. 1990;10:4239-4242.
5. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet. 1993;3:229-234. [Medline] [Order article via Infotrieve]
6.
Guzman RJ, Lemarchand P, Crystal RG, Epstein SE,
Finkel T. Efficient and selective adenovirus-mediated gene
transfer into vascular neointima.
Circulation. 1993;88:2838-2848.
7.
Guzman RJ, Lemarchand P, Crystal RG, Epstein SE,
Finkel T. Efficient gene transfer into myocardium by
direct injection of adenovirus vectors. Circ
Res. 1993;73:1202-1207.
8.
Herz J, Gerard RD. Adenovirus-mediated
transfer of low density lipoprotein receptor gene acutely accelerates
cholesterol clearance in normal mice. Proc
Natl Acad Sci U S A. 1993;90:2812-2816.
9. Jaffe JA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, Gant TW, Thorgeirsson SS, Stratford-Perricaudet LD, Perricaudet M, Pavirani A, Lecocq J-P, Crystal RG. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet. 1992;1:372-378. [Medline] [Order article via Infotrieve]
10.
Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J,
Buttrick PM, Wittenberg BA, Cipriani L, Leinwand LA.
Quantitative determination of adenovirus-mediated gene delivery to
rat cardiac myocytes in vitro and in vivo. Proc Natl Acad
Sci U S A. 1993;90:11498-11502.
11.
Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek
DA. In vivo adenoviral vector-mediated gene transfer into
balloon-injured rat carotid arteries. Circ
Res. 1993;73:797-807.
12.
Lemarchand L, Jones M, Yamada I, Crystal RG. In
vivo gene transfer and expression in normal uninjured blood vessels
using replication-deficient recombinant adenovirus vectors.
Circ Res. 1993;72:1132-1138.
13. Mastrangeli A, Danel C, Rosenfeld MA, Stratford-Perricaudet L, Perricaudet M, Pavirani A, Lecocq J-P, Crystal RG. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J Clin Invest. 1993;91:225-234.
14. Cusi D, Bianchi G. The kidney in the pathogenesis of hypertension. Semin Nephrol. 1991;11:523-537. [Medline] [Order article via Infotrieve]
15. de Wardener HE. The primary role of the kidney and salt intake in the aetiology of essential hypertension, part I. Clin Sci. 1990;79:193-200. [Medline] [Order article via Infotrieve]
16. de Wardener HE. The primary role of the kidney and salt intake in the aetiology of essential hypertension, part II. Clin Sci. 1990;79:289-297. [Medline] [Order article via Infotrieve]
17. Laragh JH. Discordant nephron function: a pathogenic factor in hypertension and its vascular complications of stroke and heart attack. Am J Hypertens. 1991;4:2s-4s.
18. Mittal SK, McDermott MR, Johnson DC, Prevec L, Graham FL. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 1993;28:67-90. [Medline] [Order article via Infotrieve]
19. Morsy MA, Alford EL, Bett A, Graham FL, Caskey CT. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J Clin Invest. 1993;92:1580-1586.
20. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, ed. Methods in Molecular Biology, Volume 7: Gene Transfer and Expression Protocols. Clifton, NJ: The Human Press Inc; 1991:109-128.
21. Holycross BJ, Peach MJ, Owens GK. Angiotensin II stimulates increased protein synthesis, not increased DNA synthesis, in intact rat aortic segments, in vitro. J Vasc Res. 1993;30:80-86. [Medline] [Order article via Infotrieve]
22. Xue H, McCarron DA, Bukoski RD. 1,25 (OH)2 vitamin D3 attenuates the loss of resistance artery contractile function associated with incubation in culture media. Biochem Biophys Res Commun. 1991;174:11-17. [Medline] [Order article via Infotrieve]
23. Braisier AR, Ron D. Luciferase reporter gene assay in mammalian cells. Methods Enzymol. 1992;216:386-397. [Medline] [Order article via Infotrieve]
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254. [Medline] [Order article via Infotrieve]
25. Du Y, Yao A, Guo DF, Inagami T, Wang DH. Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium. Hypertension. 1995;25(pt II):872-877.
26.
Loeb AL, Mandel HG, Straw JA, Bean BL. Increased
aortic DNA synthesis precedes renal hypertension in rats: an obligatory
step? Hypertension. 1986;8:754-761.
27. Labarca C, Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal Biochem. 1980;102:344-352. [Medline] [Order article via Infotrieve]
28. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. In: Ellis RW, ed. Vaccines: New Approaches to Immunological Problems. Boston, Mass: Butterworth-Heinemann; 1992:363-390.
29.
Schneider MD, French BA. The advent of
adenovirus: gene therapy for cardiovascular
disease. Circulation. 1993;88:1937-1942.
30.
Norrelund H, Christensen KL, Samani NJ, Kimber P,
Mulvany MJ, Korsgaard N. Early narrowed afferent arteriole is a
contributor to the development of hypertension.
Hypertension. 1994;24:301-308.
31.
Wang DH, Prewitt RL. Captopril reduces aortic
and microvascular growth in hypertensive and normotensive rats.
Hypertension. 1990;15:68-77.
32. Seth P, Fitzgerald D, Willingham M. Pathway of adenovirus entry into cells. In: Crowell RL, Longberg-Holm K, eds. Virus Attachment and Entry Into Cells. Washington, DC: American Society of Microbiology; 1986:191-195.
This article has been cited by other articles:
![]() |
K. Anzai, S. Yoneya, P. L. Gehlbach, D. Imai, L. L. Wei, and K. Mori Laser Photocoagulation and, to a Lesser Extent, Photodynamic Therapy Target and Enhance Adenovirus Vector-Mediated Gene Transfer in the Rat Retina Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3883 - 3891. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Oyekan, K. McAward, J. Conetta, L. Rosenfeld, and J. C. McGiff Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R766 - R775. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Onoue, M. Tsutsui, L. Smith, A. Stelter, T. O'Brien, Z. S. Katusic, and F. M. Faraci Expression and Function of Recombinant Endothelial Nitric Oxide Synthase Gene in Canine Basilar Artery After Experimental Subarachnoid Hemorrhage • Editorial Comment Stroke, September 1, 1998; 29(9): 1959 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsutsui, A. F. Y. Chen, T. O'Brien, T. B. Crotty, and Z. S. Katusic Adventitial Expression of Recombinant eNOS Gene Restores NO Production in Arteries Without Endothelium Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1231 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Maeda, U. Ikeda, Y. Ogasawara, M. Urabe, T. Takizawa, T. Saito, P. Colosi, G. Kurtzman, K. Shimada, and K. Ozawa Gene transfer into vascular cells using adeno-associated virus (AAV) vectors Cardiovasc Res, September 1, 1997; 35(3): 514 - 521. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |